Source: Medical News Today
Kaleb Michaud, Ph.D., has for a long time listened to patients with rheumatoid arthritis (RA) talking about improved quality of life after their total joint replacements. But until now, there’s been little information that actually measures how the surgery impacts quality of life for RA patients.
A recently published multi-center study provides guidance on modifiable risk factors orthopaedic surgeons can address prior to surgery to reduce the chances of patients being readmitted following total hip arthroplasty.
The U.S. Food and Drug Administration today authorized use of the first prosthesis marketed in the U.S. for adults who have amputations above the knee and who have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
A prediction model presented better estimates of the actual size of implants used in total hip arthroplasty and, in the long term, may help reduce the cost of health care by minimizing implant inventory costs, according to study results.
Henri Migaud, MD, told attendees at the recent World Arthroplasty Congress that abandoning all metal-on-metal implants for total hip arthroplasty without considering which ones could be safely used is a mistake. The right implant with the right patient can still produce a good outcome.